DrSinead Toomey

Lecturer

Department of Medicine

  • Lecturer
    Department of Medicine
  • 01 402 3823 (Work)
  • RCSI, Molecular Medicine, Education & Research Centre Beaumont Hospital

TEACHING & SUPERVISION

  • THESIS SUPERVISION
    A pilot study to determine the utility of circulating tumour DNA (ctDNA) to track clonal genomic evolution in chemoradiotherapy -resistant locally advanced rectal cancer patients
    1 Jul 2018
  • ACADEMIC ACTIVITY
    Cell Signalling and Molecular Medicine Module joint co-ordinator
    1 Mar 2018
  • THESIS SUPERVISION
    A pilot study to determine the utility of circulating tumour DNA (ctDNA) to track clonal evolution in locally advanced rectal cancer.
    1 Feb 2018 - 24 Aug 2018
  • ACADEMIC ACTIVITY
    Cell Signalling and Molecular Medicine module lecturer
    1 Feb 2017
  • THESIS SUPERVISION
    To clinically and molecularly examine the effect of copanlisib, a phosphatidylinositol 3kinase (PI3K) inhibitor, in resensitising Trastuzumab-resistant, HER2 positive advanced breast cancer in patients with advanced HER2 positive breast cancer that is resistant to anti HER2 targeted therapy during a phase IB clinical trial with an exploratory biomarker analysis using whole exome sequencing and PIK3CA mutations in circulating tumor DNA
    1 Jul 2016
  • ACADEMIC ACTIVITY
    FUN principles seminars examiner
    1 Nov 2014
  • THESIS SUPERVISION
    Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) pathways to enhance chemo-radiotherapy responsiveness in locally advanced rectal cancer
    1 Oct 2014
  • THESIS SUPERVISION
    The Role of Tyrosine-Protein Phosphatase Non-Receptor type 11 (PTPN11/SHP2) in Squamous Cell Lung Carcinoma
    1 Apr 2014